Skip to main content

and
Your search also matched 19 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Molecular predictors for decitabine efficacy in meningiomas – a pilot study

Include preview-only content
  1. Article

    Open Access

    Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status

    Johanna Jost, Klaus Völker, Ralf Brandt, Walter Stummer in Journal of Neuro-Oncology (2024)

  2. Article

    Open Access

    Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status

    Maximal cardiopulmonary exercise testing (max. CPET) provides the most accurate measurement of cardiorespiratory fitness. However, glioblastoma (GBM) patients often undergo less intensive tests, e.g., 6-min wa...

    Johanna Jost, Klaus Völker, Ralf Brandt, Walter Stummer in Journal of Neuro-Oncology (2024)

  3. Article

    Open Access

    The importance of considering competing risks in recurrence analysis of intracranial meningioma

    The risk of recurrence is overestimated by the Kaplan–Meier method when competing events, such as death without recurrence, are present. Such overestimation can be avoided by using the Aalen-Johansen method, w...

    Christian Mirian, Lasse Rehné Jensen, Tareq A. Juratli in Journal of Neuro-Oncology (2024)

  4. Article

    Open Access

    Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses

    Thomas Zeyen, Daniel Paech, Johannes Weller, Niklas Schäfer in Journal of Neuro-Oncology (2023)

  5. Article

    Open Access

    Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses

    In the randomized CeTeG/NOA-09 trial, lomustine/temozolomide (CCNU/TMZ) was superior to TMZ therapy regarding overall survival (OS) in MGMT promotor-methylated glioblastoma. Progression-free survival (PFS) and...

    Thomas Zeyen, Daniel Paech, Johannes Weller, Niklas Schäfer in Journal of Neuro-Oncology (2023)

  6. Article

    Open Access

    Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience

    Exercise proved to reduce cancer-related symptoms and prolong survival in some cancer types. However, brain tumor patients are often advised against strenuous exercise. Here, we summarize our experience with a...

    Johanna Jost, Michael Müther, Ralf Brandt, Ugur Altuner in Journal of Neuro-Oncology (2023)

  7. Article

    5-ALA fluorescence-guided surgery of CNS tumors

    Constantinos G. Hadjipanayis, Walter Stummer, Jason P. Sheehan in Journal of Neuro-Oncology (2019)

  8. Article

    Open Access

    Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients

    There is an increasing interest in local tumor ablative treatment modalities that induce immunogenic cell death and the generation of antitumor immune responses.

    Oliver Grauer, Mohammed Jaber, Katharina Hess in Journal of Neuro-Oncology (2019)

  9. Article

    Open Access

    Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery

    Survival of glioblastoma patients has been linked to the completeness of surgical resection. Available data, however, were generated with adjuvant radiotherapy. Data confirming that extensive cytoreduction rem...

    Walter Stummer, Thomas Meinel, Christian Ewelt, Peter Martus in Journal of Neuro-Oncology (2012)